Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Cash & Current Investments (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Cash & Current Investments for 10 consecutive years, with $388.9 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 21.33% to $388.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $388.9 million through Dec 2025, up 21.33% year-over-year, with the annual reading at $388.9 million for FY2025, 21.33% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $388.9 million at Rhythm Pharmaceuticals, down from $780.1 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $780.1 million in Q3 2025, with the low at $201.7 million in Q1 2024.
  • Average Cash & Current Investments over 5 years is $329.9 million, with a median of $307.3 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments surged 621.05% in 2021, then tumbled 40.43% in 2022.
  • Over 5 years, Cash & Current Investments stood at $295.2 million in 2021, then increased by 13.02% to $333.6 million in 2022, then dropped by 17.22% to $276.2 million in 2023, then grew by 16.07% to $320.6 million in 2024, then grew by 21.33% to $388.9 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $388.9 million, $780.1 million, and $291.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.